This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Jason Alter: Innovator in Prostate Cancer Evaluation
Introduction
Jason Alter is a notable inventor based in Stamford, CT (US). He has made significant contributions to the field of medical technology, particularly in the evaluation of prostate cancer. His innovative approach combines clinical, molecular, and morphometric information to enhance predictive models for medical conditions.
Latest Patents
Jason Alter holds a patent for a "System for evaluating a pathological stage of prostate cancer." This patent utilizes clinical information, molecular data, and computer-generated morphometric information to predict the likelihood of a patient having a favorable pathological stage of prostate cancer. The model incorporates various features, including preoperative PSA levels, Gleason Score, and measurements of protein expression in cell lines. This innovative system aims to improve the accuracy of prostate cancer evaluations and assist in better patient management.
Career Highlights
Throughout his career, Jason has worked with esteemed organizations, including the Champalimaud Foundation. His work has focused on integrating advanced technologies and methodologies to enhance cancer diagnostics. With one patent to his name, he has established himself as a key figure in the medical innovation landscape.
Collaborations
Jason has collaborated with professionals such as Michael Donovan and Faisal Khan. These partnerships have contributed to the development and refinement of his innovative approaches in cancer evaluation.
Conclusion
Jason Alter's contributions to the field of prostate cancer evaluation exemplify the impact of innovation in medical technology. His work continues to pave the way for advancements in predictive modeling and patient care.